Keywords: pla, filed, chiron, pertugen, product, license, application
PLA Filed For Chiron's Pertugen
Article | 07 October 1996
Chiron has filed a Product License Application in the USA for Pertugen, its diphtheria, tetanus and genetically-engineered acellular pertussis vaccine. ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Elan makes "transformational" acquisitions and a divestment
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- SciClone gains China rights to Zensun's Neucardin
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
